This chapter examines the shift of regulatory oversight from the FDA to the SEC, using the samofilam case to illustrate the need for stronger regulation in academia. It discusses the systemic issues of fraud within academic research, highlighting notable scandals and the ethical implications surrounding them. Additionally, the chapter advocates for the establishment of a nonprofit organization to combat scientific fraud, emphasizing the importance of transparency, accountability, and innovative funding mechanisms in restoring integrity to the scientific community.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode